YWYange Wei

Yange Wei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yange Wei has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Fei Wang

    Early Intervention Unit, Department of Psychiatry The Affiliated Brain Hospital of Nanjing Medical University Nanjing China

    5 shared publications
  • Rongxun Liu

    Department of Early Intervention, Mental Health and Artificial Intelligence Research Center, The Second Affiliated Hospital of Henan Medical University, Henan Mental Hospital

    4 shared publications
  • Guangjun Ji

    Department of Early Intervention, Mental Health and Artificial Intelligence Research Center, The Second Affiliated Hospital of Henan Medical University, Henan Mental Hospital

    3 shared publications
  • Guangjun Ji

    Department of Early Intervention, Mental Health and Artificial Intelligence Research Center, The Second Affiliated Hospital of Xinxiang Medical University, Henan Mental Hospital, 453002 Xinxiang, Henan, China

    3 shared publications
  • Peng Luo

    Department of Early Intervention, Mental Health and Artificial Intelligence Research Center, The Second Affiliated Hospital of Xinxiang Medical University, Henan Mental Hospital, 453002 Xinxiang, Henan, China

    3 shared publications
  • Rongxun Liu

    School of Psychology, Xinxiang Medical University, 453003 Xinxiang, Henan, China

    3 shared publications

Latest Publications

  • Open Access

    Comprehensive artificial intelligence-assisted mental health program for university students in China (CAMPUS): study protocol for a multi-center prospective cohort with planned embedded randomized intervention trials

    by Guang Yang, Rongxun Liu, Chuansheng Wang, Rongxin Zhu, Shisen Qin, Jinnan Yan, Yan Wang, Hongbo Pei, Lijuan Liang, Yingying Su, et al.

    University students face a rising prevalence of depression, anxiety, insomnia, and suicidal ideation that exceeds the capacity of conventional, resource-constrained campus support services. Although artificial intelligence (AI)-assisted screening tools have emerged, many have evaluated selected modalities or isolated prediction tasks, and their integration with prospectively evaluated intervention pathways remains limited. This protocol describes the Comprehensive Artificial Intelligence-Assisted Mental Health Program for University Students in China (CAMPUS), a multi-center research program comprising a five-year prospective cohort, eight planned embedded randomized controlled trials, and exploratory multimodal AI and multi-omics studies across seven Chinese universities. Longitudinal cohort enrolment commenced at Henan Medical University in September 2025 and is planned to expand across seven participating universities. Multidimensional screening integrates psychological self-report (PHQ-9, GAD-7, ISI, BSI-CV, and others), physiological measurements (EEG, MRI, fNIRS, HRV, eye tracking, facial-expression analysis, ERP, voice acoustics), and an exploratory biospecimen component for multi-omics profiling, potentially including genomic, transcriptomic, proteomic, metabolomic, and microbiome analyses, subject to the finalization and approval of layer-specific protocols. Students identified through cohort screening as potentially eligible for an intervention trial will undergo trial-specific eligibility assessment. Those who meet the eligibility criteria and provide trial-specific informed consent will be individually randomized in a 1:1 ratio to the intervention or its comparator within one of eight separate two-arm, multi-center, parallel-group randomized controlled trials. A Transformer-based multimodal AI framework with SHAP-based feature attribution will be developed and internally evaluated for questionnaire-defined risk stratification and exploratory treatment-response prediction. The initial Henan Medical University cohort recruitment and university-student mental-health assessment were approved by the Ethics Review Committee of Henan Medical University (XYLL-20250484), and written informed consent is obtained from participants before enrolment. Each additional participating center will obtain local ethics approval before study activation. Findings will be disseminated through peer-reviewed publications, scientific conferences, and policy briefs, providing evidence that may inform the design and prospective evaluation of youth mental-health programs in other university settings. Clinical trial registration: The two clinical trials were registered in the Chinese Clinical Trial Registry (ChiCTR). The registration details and URLs are as follows: ChiCTR2500113527: https://www.chictr.org.cn/showproj.html?proj=298271 ; ChiCTR2500113613: https://www.chictr.org.cn/showproj.html?proj=298268 .

  • Open Access

    Efficacy and mechanisms underlying MRI-guided HD-tDCS combined with aerobic exercise to ameliorate cognitive impairment associated with schizophrenia

    by Yange Wei, Zengyuan Shen, Peng Luo, Shanyuan He, Hanshuo Su, Rongxun Liu, Yanran Wu, Juan Wang, Jingdan Zhang, Guangjun Ji, et al.

    Background: The primary treatment for schizophrenia currently relies on medication. Nevertheless, the efficacy of medication for Cognitive Impairment Associated with Schizophrenia (CIAS) is constrained, and it is also accompanied by side effects. Consequently, the investigation of novel non-pharmacological strategies is essential. High-definition transcranial direct current stimulation (HD-tDCS) and aerobic exercise (AE) have emerged as promising approaches for cognitive enhancement in individuals with schizophrenia. This study aims to evaluate the efficacy of integrating HD-tDCS with AE for CIAS and to elucidate the underlying mechanisms of this synergistic intervention. Methods: A randomized, double-blind, controlled trial will be conducted. The CIAS will be randomly allocated to one of four groups: MRI-guided HD-tDCS + AE, MRI-guided HD-tDCS alone, AE alone, and a control group. Structural magnetic resonance imaging (MRI) data will be obtained to determine the optimal electrode placement. The central electrode will be positioned over the medial prefrontal cortex (mPFC). Both HD-tDCS and AE will be administered five times per week over a four-week period, resulting in a total of 20 sessions. The primary outcome measure will be the change in cognitive function, evaluated using the MATRICS Consensus Cognitive Battery. Secondary outcomes will include changes assessed by the Repeatable Battery for the Assessment of Neuropsychological Status and the Wisconsin Card Sorting Test which are designed to evaluate global and executive functions. The Facial Emotion Perception Test and the Voice Emotion Perception Test will be utilized to assess social cognition. The severity of clinical symptoms will be quantified through the Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. This study will incorporate functional near-infrared spectroscopy, MRI, electroencephalography, P300 event-related potential, eye movement examination and plasma brain-derived neurotrophic factor (BDNF) levels to investigate the underlying mechanisms. Assessments will be evaluated at baseline (T0), after 2 weeks (T1), after 4 weeks (T2), and after 6 months (T3). Discussion: The integration of MRI-guided HD-tDCS targeting the mPFC and AE presents an efficacious and individualized treatment strategy for CIAS. This proof-of-concept study may provide a multi-dimensional view of biological mechanisms underlying HD-tDCS combined with AE in precision psychiatry. Trial registration details: The study is registered with https://www.chictr.org.cn/ protocol registration number ChiCTR2500106980 (date of registration: 1. August. 2025). It was approved by the Research Ethics Committee of the Second Affiliated Hospital of Xinxiang Medical University (Approval Code: XYEFYLL-2025-16, Approval Date: 17 February 2025). Recruitment began in December 2025.

  • Open Access

    Efficacy and Mechanisms Underlying MRI-guided High-definition Transcranial Direct Current Stimulation Combined With Computerized Cognitive Remediation Therapy for Improving Cognitive Impairments in Schizophrenia: Study Protocol for a Randomized Controlled Trial

    by Yange Wei, Shanyuan He, Peng Luo, Rongxun Liu, Hanshuo Su, Zengyuan Shen, Shuqi Feng, Yanran Wu, Guangjun Ji, Wei Zheng, et al.

    Background: Schizophrenia primarily depends on pharmacotherapy, which has demonstrated limited efficacy in enhancing cognitive impairments. High-definition transcranial direct current stimulation (HD-tDCS) and computerized cognitive remediation therapy (CCRT) hold potential for improving cognitive impairments. This study aims to investigate the effects of combining HD-tDCS with CCRT on cognition and to explore the mechanisms of this approach in schizophrenia. Study Design: This is the protocol of a randomized controlled trial. Methods: Schizophrenia patients will be randomly assigned to one of 4 groups: HD-tDCS + CCRT group (Group 1), HD-tDCS group (Group 2), CCRT group (Group 3), and a control group (Group 4). The central electrode will be personalized using magnetic resonance imaging (MRI)-guided localization in the medial prefrontal cortex (mPFC). CCRT includes 6 therapeutic modules and 10 distinct tasks. Both HD-tDCS and CCRT will be administered once daily, 5 days per week, for 4 consecutive weeks, culminating in a total of 20 sessions. Assessments will occur at baseline (T0), after 10 sessions (T1), after 20 sessions (T2), and after 6 months of follow-up (T3). The primary outcome measure is the change in cognition. We will employ multimodal MRI, serum concentrations of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) to explore the underlying mechanisms. Expected Results: An involvement of mPFC and synaptic plasticity in response to HD-tDCS and CCRT is hypothesized. Conclusion: The study will provide empirical evidence for the effectiveness of combined therapy at an individual level, explore its mechanisms, and may ultimately result in personalized medicine. Clinical Trial Registration: ChiCTR2500102731, https://www.chictr.org.cn/hvshowprojectEN.html?id=276964&v=1.0.

  • Open Access

    Machine Learning Based Identification of Depressive Symptoms Among Students in a Chinese University Using Functional Near-Infrared Spectroscopy

    by Yange Wei, Yuanle Chen, Ning Wang, Huang Zheng, Zhengyun Zhan, Peng Luo, Jinnan Yan, Luhan Yang, Rongxun Liu, Guangjun Ji, et al.

    Background: Individuals suffer from depression at a high rate on university campuses and current assessment methods primarily rely on subjective questionnaires. Therefore, there is a pressing need to develop objective measures for the automatic detection of depression. This study aimed to investigate the functional near-infrared spectroscopy (fNIRS) changes associated with depression and assess the potential of fNIRS signals in detecting depression among university students. Methods: A total of 192 participants were recruited for psychological assessment. A 48-channel fNIRS system was employed to measure cerebral blood oxygenation signals during the verbal fluency task (VFT). Two-sample t-tests were used to detect group differences. The association between fNIRS data and depression was identified using Pearson correlation analysis. We applied five machine learning classifiers to differentiate depression using fNIRS signals. Model performance was evaluated using receiver operating characteristic (ROC) curves, area under the curve (AUC), precision, accuracy, recall, and F1 score. A ten-fold cross-validation incorporating the recursive feature elimination algorithm was utilized. Results: Significant hemodynamic alterations were observed in the depression group at channels 4, 16, 21, 26, 32, 43, 44, and 47, in comparison with the control group. The bilateral medial prefrontal cortices (MPFC), left dorsolateral prefrontal cortex, and left temporal lobe, represented by channels 4, 16, 43, and 44, were associated with depression. Among the five machine learning algorithms, K-Nearest-Neighbors (KNN) exhibited superior classification performance (AUC = 66.51%). The left MPFC was the most significant contributor to the classification efficacy of the KNN model. Conclusion: fNIRS-VFT may serve as an objective tool for evaluating depressive symptoms in university students. The findings underscore the central role of the left MPFC in the neural mechanisms underlying depression. This work developed an fNIRS-based identification system for depression in university students.


  • Open Access

    Efficacy and mechanisms underlying MRI-guided high-definition transcranial direct current stimulation for depression among university students: study protocol for a stepped wedge cluster randomized controlled trial

    by Yuanle Chen, Rongxun Liu, Jinnan Yan, Peng Luo, Luhan Yang, Yongbin Wang, Guangjun Ji, Chuansheng Wang, Wei Zheng, Fei Wang, et al.

    In worldwide, the prevalence of depression among university students raises year by year. Although current interventions for depression may be effective, only about one-third experiencing complete response. There is a critical need for more effective, precision, and personalized approaches for depression. High-definition transcranial direct current stimulation (HD-tDCS) shows promise as a potential intervention in depression, yet its optimal stimulation parameters and neural mechanisms remain unclear. In this study, we aim to evaluate the effectiveness of magnetic resonance imaging (MRI)-guided HD-tDCS in depression among university students and explore its neural mechanisms. In this stepped-wedge cluster randomized controlled trial, all participants will be randomly assigned to four groups. During the intervention, all groups will receive sham stimulation at week 1. With each subsequent week, one group will transition to active intervention. All groups will be receiving active intervention in week 5. Structural MRI data for each participant will be acquired to select the optimal electrode placement and correct for individual anatomical differences. The central anodal electrode will be positioned over the left dorsolateral prefrontal cortex (DLPFC), and four return electrodes will be placed 3.5 cm from the central electrode to form a circular current loop. The HD-tDCS will be delivered at a current intensity of 2 mA for 30 min per day, 5 days per week. Psychological assessment will conduct at week 0 (baseline), 1–5, and 9. MRI measurements will be performed before and after HD-tDCS. The primary outcome measures are changes in the Hamilton Rating Scale for Depression (HAMD) and Patient Health Questionnaire-9 (PHQ-9). Secondary outcomes are severity of anxiety, insomnia, and stress. Furthermore, we will employ functional near-infrared spectroscopy (fNIRS) and MRI to explore the neural mechanisms underlying the effects of HD-tDCS on depression. This study will facilitate the development of precision interventions for depression at an individual level. Multi-modal imaging approaches will provide a deepened insight into the role of MRI-guided HD-tDCS in depression and may ultimately improve intervention strategies among university students. This study is registered in https://www.chictr.org.cn/ under protocol registration number ChiCTR2400094235 (date of registration: 19. December. 2024). Recruitment will start in March 2025.


  • Open Access

    Depression Recognition Using Machine Learning Algorithms With Eye Tracking, Visual Evoked Potentials, and Auditory P300 Among Chinese Medical Students

    by Rongxun Liu, Jinnan Yan, Shisen Qin, Peng Luo, Yuanle Chen, Luhan Yang, Guangjun Ji, Chao Wang, Xuebing Huang, Fei Wang, et al.

    Background: Current assessment of depression primarily relies on psychological scales. Although the use of machine learning in depression has grown, limited reports are available on multiple neurophysiological measurements. We employed machine learning algorithms incorporating eye tracking, visual evoked potentials (VEPs), and auditory P300 to classify depression among Chinese medical students. Methods: A total of 66 students with depression and 72 matched controls were recruited; eye tracking, VEPs, and auditory P300 data were collected. Descriptive analyses and group comparisons were performed between the depression and control groups. Then, multivariate logistic regression (LR) analysis was conducted to evaluate the relationship between eye tracking, VEPs, and auditory P300 features and Patient Health Questionnaire‐9 (PHQ‐9) scores. Furthermore, the study employed six classifiers to differentiate between depression and nondepression. Five‐fold cross‐validation was employed. Model performance was assessed using receiver operating characteristic (ROC) curves, area under the curve (AUC), precision, accuracy, recall, and F1 score. We applied SHapley Additive exPlanations (SHAP) values to explain the model. Results: Depression group was characterized by lower response search scores, higher D values, and prolonged P100 latencies in both eyes. No significant differences were observed in auditory P300 features. Random forest (RF) classifier demonstrated superior classification performance relative to the other five machine learning algorithms. Models utilizing combined features showed enhanced performance compared with those based solely on eye tracking or VEP features. Utilizing the SHAP method, we identified that P100 latency in the right eye was the most significant feature across all machine learning models. Conclusions: Chinese medical students with depression exhibited reduced responsive search scores and extended P100 latencies, suggesting impairments in attention and visual information processing associated with depression. The combined eye tracking and VEPs proved to be more effective than single features for distinguishing depression and nondepression. P100 latency in the right eye may be the most significant predictor of depression.


  • Effectiveness of a Biofeedback Intervention Targeting Mental and Physical Health Among College Students Through Speech and Physiology as Biomarkers Using Machine Learning: A Randomized Controlled Trial

    by Lifei Wang, Rongxun Liu, Yang Wang, Xiao Xu, Ran Zhang, Yange Wei, Rongxin Zhu, Xizhe Zhang, Fei Wang

    Biofeedback therapy is mainly based on the analysis of physiological features to improve an individual’s affective state. There are insufficient objective indicators to assess symptom improvement after biofeedback. In addition to psychological and physiological features, speech features can precisely convey information about emotions. The use of speech features can improve the objectivity of psychiatric assessments. Therefore, biofeedback based on subjective symptom scales, objective speech, and physiological features to evaluate efficacy provides a new approach for early screening and treatment of emotional problems in college students. A 4-week, randomized, controlled, parallel biofeedback therapy study was conducted with college students with symptoms of anxiety or depression. Speech samples, physiological samples, and clinical symptoms were collected at baseline and at the end of treatment, and the extracted speech features and physiological features were used for between-group comparisons and correlation analyses between the biofeedback and wait-list groups. Based on the speech features with differences between the biofeedback intervention and wait-list groups, an artificial neural network was used to predict the therapeutic effect and response after biofeedback therapy. Through biofeedback therapy, improvements in depression (p = 0.001), anxiety (p = 0.001), insomnia (p = 0.013), and stress (p = 0.004) severity were observed in college-going students (n = 52). The speech and physiological features in the biofeedback group also changed significantly compared to the waitlist group (n = 52) and were related to the change in symptoms. The energy parameters and Mel-Frequency Cepstral Coefficients (MFCC) of speech features can predict whether biofeedback intervention effectively improves anxiety and insomnia symptoms and treatment response. The accuracy of the classification model built using the artificial neural network (ANN) for treatment response and non-response was approximately 60%. The results of this study provide valuable information about biofeedback in improving the mental health of college-going students. The study identified speech features, such as the energy parameters, and MFCC as more accurate and objective indicators for tracking biofeedback therapy response and predicting efficacy. Trial Registration ClinicalTrials.gov ChiCTR2100045542.


  • Open Access

    Sex-specific immune-inflammatory markers and lipoprotein profile in patients with anhedonia with unipolar and bipolar depression

    by Shengjuan Lin, Rongxun Liu, Zhongguo Zhang, Fengyi Liu, Shisen Qin, Yange Wei, Fei Wang

    Background: Anhedonia is a core symptom in patients with unipolar and bipolar depression. However, sex-specific markers reflecting biological heterogeneity are lacking. Emerging evidence suggests that sex differences in immune-inflammatory markers and lipoprotein profiles are associated with anhedonia. Methods: The demographic and clinical data, immune-inflammatory markers (CD3, CD4, and CD8), and lipoprotein profiles [TC, TG, LDL-C, HDL-C, lipoprotein(a) Lp (a)] of 227 patients with unipolar and bipolar depression were collected. The Hamilton Depression Rating Scale (HAMD) and Snaith-Hamilton Pleasure Scale (SHAPS) were used to assess depression and anhedonia symptoms. Data were analyzed using ANOVA, logistic regression, and receiver operating characteristic curves. Results: Male patients in the anhedonia group had higher levels of CD3, CD4, and CD8, and lower levels of Lp (a) than the non-anhedonia group, while no significant difference was identified in female patients with and without anhedonia. Logistic regression analysis showed that CD3, CD4, CD8, and Lp (a) levels were associated with anhedonia in male patients. Furthermore, the combination of CD3, CD4, CD8, and Lp (a) had the strongest predictive value for distinguishing anhedonia in male patients than individual parameters. Conclusions: We identified sex-specific associations between immune-inflammatory markers, lipoprotein profiles, and anhedonia in patients with unipolar and bipolar depression. The combination of CD3, CD4, CD8, and Lp (a) might be a possible biomarker for identifying anhedonia in male patients with unipolar and bipolar depression.